Correlation Between Virax Biolabs and Curis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Curis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Curis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Curis Inc, you can compare the effects of market volatilities on Virax Biolabs and Curis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Curis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Curis.

Diversification Opportunities for Virax Biolabs and Curis

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Virax and Curis is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Curis Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Curis Inc and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Curis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Curis Inc has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Curis go up and down completely randomly.

Pair Corralation between Virax Biolabs and Curis

Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Curis. In addition to that, Virax Biolabs is 2.49 times more volatile than Curis Inc. It trades about -0.1 of its total potential returns per unit of risk. Curis Inc is currently generating about -0.07 per unit of volatility. If you would invest  553.00  in Curis Inc on August 30, 2024 and sell it today you would lose (108.00) from holding Curis Inc or give up 19.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Virax Biolabs Group  vs.  Curis Inc

 Performance 
       Timeline  
Virax Biolabs Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Curis Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Curis Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Virax Biolabs and Curis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virax Biolabs and Curis

The main advantage of trading using opposite Virax Biolabs and Curis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Curis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Curis will offset losses from the drop in Curis' long position.
The idea behind Virax Biolabs Group and Curis Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets